Peter Santer, D.Phil., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Midodrine | 2 | 2021 | 24 | 1.450 |
Why?
|
Respiration Disorders | 6 | 2022 | 364 | 1.280 |
Why?
|
Hypotension | 3 | 2022 | 888 | 1.060 |
Why?
|
Anesthesia, General | 10 | 2024 | 1189 | 0.810 |
Why?
|
Etomidate | 4 | 2020 | 185 | 0.780 |
Why?
|
Respiratory Insufficiency | 4 | 2023 | 1240 | 0.750 |
Why?
|
Ventilator-Induced Lung Injury | 1 | 2022 | 135 | 0.730 |
Why?
|
Maltose | 1 | 2020 | 39 | 0.700 |
Why?
|
Respiration, Artificial | 12 | 2024 | 2726 | 0.690 |
Why?
|
Ambulatory Surgical Procedures | 3 | 2021 | 452 | 0.680 |
Why?
|
Ferric Compounds | 1 | 2020 | 376 | 0.610 |
Why?
|
Anesthesia, Conduction | 1 | 2021 | 263 | 0.570 |
Why?
|
Intraoperative Care | 2 | 2024 | 770 | 0.570 |
Why?
|
Exercise Tolerance | 1 | 2020 | 846 | 0.480 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2021 | 888 | 0.470 |
Why?
|
Oxygen | 2 | 2021 | 4270 | 0.400 |
Why?
|
Tidal Volume | 4 | 2023 | 518 | 0.400 |
Why?
|
Dyspnea | 1 | 2020 | 1352 | 0.400 |
Why?
|
Sleep Apnea, Obstructive | 3 | 2020 | 1899 | 0.390 |
Why?
|
Postoperative Complications | 11 | 2024 | 15832 | 0.380 |
Why?
|
Deep Sedation | 2 | 2021 | 119 | 0.330 |
Why?
|
Hypnotics and Sedatives | 5 | 2022 | 1191 | 0.320 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2020 | 3252 | 0.300 |
Why?
|
Lipopolysaccharides | 1 | 2015 | 2219 | 0.290 |
Why?
|
Vasoconstrictor Agents | 2 | 2021 | 656 | 0.270 |
Why?
|
Inflammation Mediators | 1 | 2015 | 1892 | 0.270 |
Why?
|
Propofol | 2 | 2022 | 608 | 0.260 |
Why?
|
Delirium | 3 | 2022 | 1697 | 0.250 |
Why?
|
Neuromuscular Blocking Agents | 2 | 2021 | 132 | 0.220 |
Why?
|
Intensive Care Units | 6 | 2024 | 3800 | 0.220 |
Why?
|
Neuromuscular Blockade | 2 | 2021 | 148 | 0.210 |
Why?
|
Polysomnography | 2 | 2020 | 1871 | 0.210 |
Why?
|
Continuous Positive Airway Pressure | 2 | 2019 | 580 | 0.210 |
Why?
|
Retrospective Studies | 23 | 2024 | 81762 | 0.200 |
Why?
|
Delayed Emergence from Anesthesia | 1 | 2021 | 10 | 0.200 |
Why?
|
Intubation, Intratracheal | 2 | 2020 | 1359 | 0.190 |
Why?
|
Ventilators, Mechanical | 1 | 2024 | 292 | 0.190 |
Why?
|
Calgranulin A | 1 | 2021 | 81 | 0.190 |
Why?
|
Calgranulin B | 1 | 2021 | 87 | 0.190 |
Why?
|
Sepsis | 1 | 2015 | 2608 | 0.190 |
Why?
|
Neutrophil Activation | 1 | 2021 | 180 | 0.180 |
Why?
|
Registries | 7 | 2021 | 8375 | 0.180 |
Why?
|
Nitrous Oxide | 1 | 2021 | 166 | 0.180 |
Why?
|
Neuromuscular Depolarizing Agents | 1 | 2020 | 44 | 0.180 |
Why?
|
Succinylcholine | 1 | 2020 | 67 | 0.180 |
Why?
|
Analgesics, Opioid | 3 | 2021 | 3837 | 0.170 |
Why?
|
Ventilator Weaning | 2 | 2022 | 170 | 0.170 |
Why?
|
Anesthesia | 2 | 2023 | 1596 | 0.170 |
Why?
|
Sulfonic Acids | 1 | 2020 | 103 | 0.170 |
Why?
|
Antiemetics | 1 | 2021 | 188 | 0.170 |
Why?
|
Nervous System Physiological Phenomena | 1 | 2020 | 114 | 0.160 |
Why?
|
Respiratory System | 2 | 2022 | 564 | 0.160 |
Why?
|
Anesthesia, Epidural | 1 | 2021 | 232 | 0.160 |
Why?
|
Patient Discharge | 2 | 2023 | 3479 | 0.160 |
Why?
|
Vaccines, Synthetic | 1 | 2021 | 622 | 0.160 |
Why?
|
Hospitals | 6 | 2021 | 3886 | 0.150 |
Why?
|
Time | 1 | 2020 | 552 | 0.150 |
Why?
|
Platelet Activation | 1 | 2021 | 644 | 0.150 |
Why?
|
Adult | 24 | 2024 | 223646 | 0.150 |
Why?
|
Coma | 1 | 2021 | 485 | 0.140 |
Why?
|
Lung | 6 | 2023 | 10099 | 0.140 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2020 | 520 | 0.140 |
Why?
|
Operating Rooms | 1 | 2024 | 790 | 0.140 |
Why?
|
Positive-Pressure Respiration | 1 | 2022 | 713 | 0.140 |
Why?
|
Analgesics | 2 | 2021 | 1071 | 0.140 |
Why?
|
Cardiovascular Diseases | 2 | 2022 | 15662 | 0.140 |
Why?
|
Nose | 1 | 2021 | 522 | 0.140 |
Why?
|
Airway Management | 1 | 2020 | 326 | 0.140 |
Why?
|
Disease Models, Animal | 2 | 2020 | 18349 | 0.140 |
Why?
|
Peripheral Nerves | 1 | 2021 | 490 | 0.140 |
Why?
|
Length of Stay | 5 | 2021 | 6498 | 0.140 |
Why?
|
Humans | 43 | 2024 | 768166 | 0.140 |
Why?
|
Australia | 1 | 2020 | 1265 | 0.140 |
Why?
|
Adrenomedullin | 1 | 2016 | 85 | 0.140 |
Why?
|
Dexmedetomidine | 1 | 2021 | 320 | 0.130 |
Why?
|
Fentanyl | 1 | 2020 | 451 | 0.130 |
Why?
|
Perioperative Care | 2 | 2024 | 1043 | 0.130 |
Why?
|
Ketamine | 1 | 2022 | 527 | 0.130 |
Why?
|
Resistin | 1 | 2016 | 172 | 0.130 |
Why?
|
GABA Modulators | 1 | 2016 | 109 | 0.130 |
Why?
|
Pulmonary Gas Exchange | 1 | 2017 | 389 | 0.130 |
Why?
|
Anesthesiology | 2 | 2023 | 1137 | 0.120 |
Why?
|
Anesthetics, Inhalation | 1 | 2020 | 573 | 0.120 |
Why?
|
Endothelin-1 | 1 | 2016 | 296 | 0.120 |
Why?
|
Infusions, Intravenous | 2 | 2021 | 2230 | 0.120 |
Why?
|
Respiration | 1 | 2021 | 1665 | 0.120 |
Why?
|
Postoperative Period | 1 | 2019 | 1826 | 0.120 |
Why?
|
Receptors, GABA-A | 2 | 2016 | 625 | 0.120 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2021 | 1354 | 0.110 |
Why?
|
Postoperative Care | 1 | 2020 | 1480 | 0.110 |
Why?
|
Hemoglobins | 1 | 2020 | 1531 | 0.110 |
Why?
|
Mitogen-Activated Protein Kinase 14 | 1 | 2014 | 29 | 0.110 |
Why?
|
Aged | 18 | 2024 | 171504 | 0.110 |
Why?
|
Disability Evaluation | 1 | 2021 | 1835 | 0.110 |
Why?
|
Pain, Postoperative | 2 | 2021 | 1765 | 0.110 |
Why?
|
Proteoglycans | 1 | 2016 | 809 | 0.110 |
Why?
|
Respiratory Tract Diseases | 1 | 2019 | 744 | 0.110 |
Why?
|
Hospital Mortality | 3 | 2021 | 5349 | 0.100 |
Why?
|
Rats, Sprague-Dawley | 4 | 2020 | 8128 | 0.100 |
Why?
|
Lower Extremity | 1 | 2021 | 1216 | 0.100 |
Why?
|
Respiratory Function Tests | 1 | 2017 | 1695 | 0.100 |
Why?
|
Middle Aged | 18 | 2024 | 223492 | 0.100 |
Why?
|
Proteome | 1 | 2021 | 1890 | 0.090 |
Why?
|
Male | 23 | 2024 | 364719 | 0.090 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 2011 | 0.090 |
Why?
|
Anesthetics, Intravenous | 1 | 2014 | 397 | 0.090 |
Why?
|
Health Care Costs | 1 | 2024 | 3239 | 0.090 |
Why?
|
Massachusetts | 2 | 2024 | 8890 | 0.090 |
Why?
|
Quality Indicators, Health Care | 1 | 2021 | 1805 | 0.090 |
Why?
|
Orthopedic Procedures | 1 | 2021 | 1279 | 0.090 |
Why?
|
Blood Platelets | 1 | 2021 | 2479 | 0.090 |
Why?
|
Carbon | 1 | 2014 | 673 | 0.090 |
Why?
|
Cohort Studies | 9 | 2024 | 41754 | 0.090 |
Why?
|
Aged, 80 and over | 9 | 2022 | 59629 | 0.090 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2014 | 483 | 0.090 |
Why?
|
Lung Diseases | 1 | 2020 | 1944 | 0.080 |
Why?
|
Female | 24 | 2024 | 397192 | 0.080 |
Why?
|
Antibodies, Viral | 1 | 2021 | 3216 | 0.080 |
Why?
|
Vertebral Artery | 1 | 2010 | 185 | 0.080 |
Why?
|
Hemodynamics | 1 | 2020 | 4194 | 0.080 |
Why?
|
Rats | 5 | 2020 | 23760 | 0.080 |
Why?
|
Disease Management | 1 | 2020 | 2536 | 0.080 |
Why?
|
Double-Blind Method | 2 | 2020 | 12465 | 0.080 |
Why?
|
Vaccination | 1 | 2021 | 3437 | 0.080 |
Why?
|
Neutrophils | 1 | 2021 | 3786 | 0.080 |
Why?
|
Surgical Procedures, Operative | 1 | 2020 | 1932 | 0.080 |
Why?
|
Patient Readmission | 1 | 2021 | 3288 | 0.070 |
Why?
|
MAP Kinase Signaling System | 1 | 2014 | 1494 | 0.070 |
Why?
|
Young Adult | 7 | 2021 | 60066 | 0.070 |
Why?
|
Quality Improvement | 1 | 2021 | 3857 | 0.060 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2016 | 3514 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2016 | 3603 | 0.060 |
Why?
|
Mass Screening | 1 | 2020 | 5458 | 0.060 |
Why?
|
Thyroid Gland | 1 | 2010 | 1171 | 0.060 |
Why?
|
Propensity Score | 2 | 2021 | 1969 | 0.050 |
Why?
|
Oxidative Stress | 1 | 2014 | 3139 | 0.050 |
Why?
|
Work of Breathing | 1 | 2022 | 57 | 0.050 |
Why?
|
Models, Biological | 1 | 2017 | 9495 | 0.050 |
Why?
|
Xenopus laevis | 2 | 2016 | 967 | 0.050 |
Why?
|
Neuromuscular Nondepolarizing Agents | 1 | 2020 | 145 | 0.040 |
Why?
|
Adolescent | 4 | 2020 | 89169 | 0.040 |
Why?
|
Vitamin K | 1 | 2022 | 314 | 0.040 |
Why?
|
Death | 1 | 2024 | 683 | 0.040 |
Why?
|
Inflammation | 2 | 2016 | 10873 | 0.040 |
Why?
|
Quality of Life | 1 | 2020 | 13490 | 0.040 |
Why?
|
Snoring | 1 | 2020 | 211 | 0.040 |
Why?
|
Azepines | 1 | 2020 | 329 | 0.040 |
Why?
|
New England | 1 | 2021 | 1058 | 0.040 |
Why?
|
Extracellular Matrix Proteins | 1 | 2022 | 832 | 0.040 |
Why?
|
Apoptosis | 1 | 2014 | 9523 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13586 | 0.040 |
Why?
|
Calcium-Binding Proteins | 1 | 2022 | 1083 | 0.040 |
Why?
|
Prospective Studies | 4 | 2022 | 54926 | 0.030 |
Why?
|
Risk Factors | 5 | 2022 | 74944 | 0.030 |
Why?
|
Area Under Curve | 1 | 2021 | 1643 | 0.030 |
Why?
|
Pregnant Women | 1 | 2021 | 576 | 0.030 |
Why?
|
Breath Tests | 1 | 2017 | 300 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2020 | 10760 | 0.030 |
Why?
|
Risk Assessment | 3 | 2023 | 24315 | 0.030 |
Why?
|
Heart Failure | 1 | 2020 | 11879 | 0.030 |
Why?
|
Benzodiazepines | 1 | 2022 | 1138 | 0.030 |
Why?
|
Laryngoscopy | 1 | 2020 | 714 | 0.030 |
Why?
|
Intraoperative Complications | 1 | 2022 | 1171 | 0.030 |
Why?
|
Morbidity | 1 | 2020 | 1755 | 0.030 |
Why?
|
Fluid Therapy | 1 | 2019 | 587 | 0.030 |
Why?
|
Adrenal Cortex Diseases | 1 | 2014 | 13 | 0.030 |
Why?
|
Triazoles | 1 | 2020 | 904 | 0.030 |
Why?
|
Lethal Dose 50 | 1 | 2014 | 71 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15454 | 0.030 |
Why?
|
GABA Agonists | 1 | 2014 | 106 | 0.030 |
Why?
|
Adrenal Cortex | 1 | 2014 | 134 | 0.030 |
Why?
|
Animals | 5 | 2020 | 169246 | 0.030 |
Why?
|
Indicators and Reagents | 1 | 2014 | 456 | 0.030 |
Why?
|
Stereoisomerism | 1 | 2014 | 612 | 0.030 |
Why?
|
Molecular Conformation | 1 | 2014 | 540 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3628 | 0.030 |
Why?
|
Nursing Homes | 1 | 2020 | 1084 | 0.030 |
Why?
|
Solubility | 1 | 2014 | 1083 | 0.030 |
Why?
|
Rats, Inbred Lew | 1 | 2014 | 1162 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20227 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2022 | 3205 | 0.020 |
Why?
|
Time Factors | 2 | 2021 | 40218 | 0.020 |
Why?
|
Obesity, Morbid | 1 | 2020 | 1298 | 0.020 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2021 | 2185 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2014 | 3055 | 0.020 |
Why?
|
Pregnancy | 2 | 2021 | 30256 | 0.020 |
Why?
|
Risk | 1 | 2020 | 9613 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9374 | 0.020 |
Why?
|
Proteomics | 1 | 2021 | 3912 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2020 | 3941 | 0.020 |
Why?
|
Logistic Models | 1 | 2021 | 13290 | 0.020 |
Why?
|
Patient Compliance | 1 | 2016 | 2697 | 0.020 |
Why?
|
Stroke Volume | 1 | 2020 | 5622 | 0.020 |
Why?
|
Arteries | 1 | 2010 | 1127 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2021 | 17140 | 0.010 |
Why?
|
Myocytes, Cardiac | 1 | 2014 | 1681 | 0.010 |
Why?
|
Sleep | 1 | 2020 | 4819 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5367 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 22291 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2892 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2020 | 65371 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18412 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 10399 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15948 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2021 | 26422 | 0.010 |
Why?
|
Cell Line | 1 | 2014 | 15597 | 0.010 |
Why?
|
Brain | 1 | 2021 | 27360 | 0.010 |
Why?
|
Mice | 1 | 2014 | 82029 | 0.000 |
Why?
|